IRadimed Stock Year Fund Signals Growth and Risk in 2026
A large fund trimmed its IRADIMED stake while the company posted a record quarter, sparking discussion about growth, ...
Implement a cashback strategy that targets debt directly, converting rewards into meaningful reductions each month.
22,486 articlesA large fund trimmed its IRADIMED stake while the company posted a record quarter, sparking discussion about growth, ...
Investors tracking UiPath PATH know 2027 will hinge on cloud adoption, service expansion, and pricing power. This gui...
Marvell Technology recently reached a new high, prompting questions about its staying power. This guide breaks down t...
Being first to a big-market shift can pay off, but it often costs tens of billions in dollars and investor confidence...
A 50-person consultancy hired its first full-stack developer this January as Meta cuts thousands of jobs and AI resha...
A hot new Snowflake product could change how companies store and analyze data. This guide breaks down what it means f...
Jamie Dimon drops a bold note on AI’s real impact at JPMorgan: it’s already trimming headcount in some units, but pro...
SoundHound AI is pursuing an enterprise voice AI niche built on data ownership and brand protection. This article bre...
A wave of enthusiasm for AI infrastructure helped Tower Semiconductor leap higher this week. Investors spotlighted si...
Nike has steadied after a challenging period, yet investors should brace for the real test: translating a stabilized ...
As pharmacy discounts proliferate, insured customers may chase lower prices at the counter only to discover long-term...
Two popular ETFs populate the healthcare investing scene: PPH focuses narrowly on drugmakers, while IXJ spans the bro...